Walgreens Boots Alliance, Inc. (WBA)
NASDAQ: WBA · Real-Time Price · USD
9.55
+0.20 (2.14%)
At close: Dec 20, 2024, 4:00 PM
9.54
-0.01 (-0.10%)
After-hours: Dec 20, 2024, 7:59 PM EST
Walgreens Boots Alliance Market Cap
Walgreens Boots Alliance has a market cap or net worth of $8.26 billion as of December 20, 2024. Its market cap has decreased by -58.28% in one year.
Market Cap
8.26B
Enterprise Value
39.00B
1-Year Change
-58.28%
Ranking
Category
Stock Price
$9.55
Market Cap Chart
Since December 1, 1998, Walgreens Boots Alliance's market cap has decreased from $26.43B to $8.26B, a decrease of -68.76%. That is a compound annual growth rate of -4.36%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Dec 20, 2024 | 8.26B | -63.39% |
Dec 29, 2023 | 22.56B | -30.19% |
Dec 30, 2022 | 32.31B | -28.44% |
Dec 31, 2021 | 45.15B | 30.75% |
Dec 31, 2020 | 34.53B | -34.38% |
Dec 31, 2019 | 52.62B | -18.37% |
Dec 31, 2018 | 64.47B | -12.07% |
Dec 29, 2017 | 73.31B | -18.22% |
Dec 30, 2016 | 89.65B | -3.30% |
Dec 31, 2015 | 92.72B | 28.67% |
Dec 31, 2014 | 72.06B | 32.03% |
Dec 31, 2013 | 54.58B | 56.03% |
Dec 31, 2012 | 34.98B | 21.12% |
Dec 30, 2011 | 28.88B | -20.28% |
Dec 31, 2010 | 36.22B | -0.24% |
Dec 31, 2009 | 36.31B | 48.76% |
Dec 31, 2008 | 24.41B | -35.35% |
Dec 31, 2007 | 37.75B | -18.02% |
Dec 29, 2006 | 46.05B | 2.80% |
Dec 30, 2005 | 44.79B | 14.25% |
Dec 31, 2004 | 39.21B | 5.12% |
Dec 31, 2003 | 37.30B | 24.67% |
Dec 31, 2002 | 29.92B | -12.87% |
Dec 31, 2001 | 34.34B | -18.93% |
Dec 29, 2000 | 42.36B | 44.09% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Bio-Rad Laboratories | 9.13B |
Bio-Rad Laboratories | 9.08B |
Henry Schein | 8.73B |
Bruker | 8.43B |
Roivant Sciences | 8.40B |
Ascendis Pharma | 8.18B |
Repligen | 8.17B |
HealthEquity | 8.14B |